Fimlab laboratories   Report issue

For profit Phase 3
Founded: Tampere Finland (2011)

Organization Overview

First Clinical Trial
2012
NCT01821404
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fimlab laboratories

Active Ingredients

Drugs in Phase 3 Trials (1)

atorvastatin (lipitor) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Prostatic Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1